2022 / 02

Следующая статья
DOI: 10.24075/medet.2022.048

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ

Перспективы использования технологий редактирования генома человека: риски, проблемы, правовое регулирование

А. А. Пестрикова
Информация об авторах

Тольяттинский государственный университет, Тольятти, Россия

Для корреспонденции: Анастасия Александровна Пестрикова
ул. Мичурина, 154–165, г. Самара, 443086, Россия; ur.xednay@108aisatsana

Статья получена: 21.04.2022 Статья принята к печати: 27.05.2022 Опубликовано online: 30.06.2022
|
  1. WHO expert advisory committee on developing global standards for governance and oversight of human genome editing: report of the sixth meeting. Режим доступа: [Электронный ресурс]. URL: https://www.who.int/publications/i/item/who-expert-advisory-committee-on-developing-global-standards-for-governance-and-oversight-of-human-genome-editing-report-of-the-sixth-meeting.
  2. Park S, and Beal PA. Off-target editing by crispr-guided dna base editors. Biochemistry. 2019; 58: 3727–3734. DOI: 10.1021/acs. biochem.9b00573
  3. Zhang X-H, Tee, L Y, Wang X-G, Huang Q-S, and Yang S-H. Offtarget effects in crispr/cas9-mediated genome engineering. Mol Ther Nucleic Acids. 201; 4: e264. DOI: 10.1038/mtna.2015.37
  4. Biesecker LG, and Spinner NB. A genomic view of mosaicism and human disease. Nat Rev Genet. 2013; 14: 307–320. DOI: 10.1038/nrg3424
  5. Archer NM, Petersen N, Clark MA, Buckee CO, Childs LM, and Duraisingh MT. Resistance to plasmodium falciparum in sickle cell trait erythrocytes is driven by oxygen-dependent growth inhibition. Proc Natl Acad Sci U. S.A. 2018; 115: 7350–7355. DOI: 10.1073/ pnas.1804388115
  6. Baylis F, Darnovsky M, Hasson K, and Krahn TM. Human germline and heritable genome editing: the global policy landscape. CRISPR J. 2020; 3: 365–377. DOI: 10.1089/crispr.2020.0082
  7. Macintosh KL. Heritable genome editing and the downsides of a global moratorium. CRISPR J. 2019; 2: 272–279. DOI: 10.1089/ crispr.2019.0016
  8. Helicos went bankrupt in 2012 and SeqLL bought all its intellectual property and hardware // http://seqll.com
  9. Konig H. Germline-editing moratorium — why we should resist it. Nature. 2019; 458 p. DOI: 10.1038/d41586–019–01292–6
  10. Lander ES, Baylis F, Zhang F, Charpentier E, Berg P, Bourgain C, et al. Adopt a moratorium on heritable genome editing. Nature. 2019; 567: 165–168. DOI: 10.1038/d41586–019–00726–5
  11. Normile D. Shock greets claim of crispr-edited babies. Science. 2018; 362: 978–979. DOI: 10.1126/science.362.6418.978
  12. Cyranoski D. What crispr-baby prison sentences mean for research. Nature. 2020; 577: 154–155. DOI: 10.1038/d41586–020–00001-y
  13. Joy MT, Assayag EB, Shabashov-Stone D, Liraz-Zaltsman S, Mazzitelli J, Arenas M, et al. Ccr5 is a therapeutic target for recovery after stroke and traumatic brain injury. Cell. 2019;176: 1143–1157.e13. DOI: 10.1016/j.cell.2019.01.044
  14. Fletcher JC, and Anderson WF. Germ-line gene therapy: a new stage of debate. Law Med Health Care. 1992; 20: 26–39. DOI: 10.1111/j.1748–720X.1992.tb01171.x
  15. Wilholt T. Die Freiheit Der Forschung: Begründungen Und Begrenzungen. Berlin: Suhrkamp, 2012.
  16. The protection of the human embryo in vitro. Report by the Working Party on the Protection of the Human Embryo and Fetus (CDBI-CO-GT3). Режим доступа: [Электронный ресурс]. URL: http://www.coe.int/t/dg3/healthbioethic/activities/04_human_embryo_and_foetus_en/GT3%20(2003)13%20.
  17. Brinegar K, Yetisen AK, Choi S, Vallillo E, Ruiz-Esparza GU, Prabhakar A M, et al. The commercialization of genome-editing technologies. Crit Rev Biotechnol. 2017; 37: 924–932. DOI: 10.1080/07388551.2016.1271768
  18. Thompson DF. Understanding financial conflicts of interest. N Engl J Med. 1993; 329: 573–576. DOI: 10.1056/NEJM199308193290812
  19. Lieb K, Klemperer D, Kolbel R, and Ludwig W-D, (eds.). Interessenkonflikte, Korruption und Compliance im Gesundheitswesen. Berlin: Medizinisch Wissenschaftliche Buchgesellschaft, 2018.
  20. Krimsky S. Conflicts of Interest in Science: How CorporateFunded Academic Research Can Threaten Public Health. New York: Skyhorse, 2018.
  21. Mahla RS. Stem cells applications in regenerative medicine and disease therapeutics. Int J Cell Biol. 2016; 1–24. DOI: 10.1155/2016/6940283
  22. Dollars for Profs. Dig Into University Researchers' Outside Income and Conflicts of Interest By Sisi Wei, Annie Waldman and David Armstrong, ProPublica. Published December 6, 2019. Режим доступа: [Электронный ресурс]. URL: https://projects.propublica.org/dollars-for-profs